FDA Adverse Event Malfunction Summary report: N

EPLEX BLOOD CULTURE IDENTIFICATION GRAM NEGATIVE (BCID-GN) PANEL

MDR report key: 21833124 · Received April 14, 2025

Report

Report Number
3008632402-2025-01122
Event Type
Malfunction
Date Received
April 14, 2025
Date of Event
March 18, 2025
Report Date
May 2, 2025
Manufacturer
GENMARK DIAGNOSTICS, INC.
Product Code
PEN
PMA / PMN Number
K182619
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE GM EPLEX BASE UNIT SERIAL NUMBER WAS (B)(6). NO MALFUNCTION WAS FOUND FOR THE EPLEX INSTRUMENT, AND IT WAS WORKING WITHIN SPECIFICATION. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. ANTIMICROBIAL RESISTANCE CAN OCCUR VIA MULTIPLE MECHANISMS, AND THE BCID-GN PANEL IS DESIGNED TO DIRECTLY DETECT THE NUCLEIC ACID OF A RESISTANCE GENE. A 'NOT DETECTED' RESULT FOR AN ANTIMICROBIAL RESISTANCE GENE SHOULD NOT BE INTERPRETED AS ANTIMICROBIAL SUSCEPTIBILITY TO A SPECIFIC ORGANISM. IN ADDITION, ESBL RESISTANCE CAN BE DUE TO MECHANISMS OTHER THAN THE ACQUISITION OF THE CTX-M RESISTANCE GENE. A 'NOT DETECTED' FOR THE SPECIFIC CTX-M RESISTANCE GENE PRESENT IN THE E. COLI MAY BE DUE TO SEQUENCE VARIATION AND/OR ASSAY LIMITATION.

Description of Event or Problem · 0

THERE WAS AN ALLEGATION OF FALSE NEGATIVE CTX-M RESULT WHILE USING THE EPLEX BLOOD CULTURE IDENTIFICATION GRAM NEGATIVE (BCID-GN) PANEL ON A GM EPLEX BASE UNIT. THE RESULT FROM THE EPLEX WAS NO DETECTION FOR ANY OF THE RESISTANCE GENES AND DETECTED FOR E. COLI. THE CULTURE RESULT WAS E. COLI. EXTENDED-SPECTRUM BETA-LACTAMASES (ESBL) WAS CONFIRMED USING PHOENIX ESBL TEST. REFER TO THE ATTACHMENT TO MEDWATCH FOR THE SUSCEPTIBILITY TESTING RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1080542 EPLEX BLOOD CULTURE IDENTIFICATION GRAM NEGATIVE (BCID-GN) PANEL GRAM-NEGATIVE BACTERIA AND ASSOCIATED RESISTANCE MARKERS PEN GENMARK DIAGNOSTICS, INC. 10230394

Patients

Seq Age Sex Outcome Treatment
1 57 YR Female